Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bill Gates On Vaccine Distribution Challenges, Overcoming Vaccine Hesitancy

Executive Summary

The public health advocate and billionaire philanthropist raised issues about how a mass COVID-19 vaccination effort is being handled so far in the US, speaking at the Stat Summit.

You may also be interested in...



Pfizer Is Ready To File Vaccine, With More Good News On Over-65s Efficacy

Pfizer is moving swiftly towards an emergency use approval filing, with Moderna not far behind.

Pfizer Pilots COVID-19 Immunization Plan In Four States As ‘Dry Run’

The company's Phase III COVID-19 vaccine trial has reached the needed safety data required for filing an emergency use authorization with the FDA, Bourla confirmed at the Stat Summit.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC143340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel